









Markets
/
Stocks
/
nasdaq-telo
/

Telomir Pharmaceuticals Inc

TELO

1.160USD

-0.100-7.94%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

34.35MMarket Cap

LossP/E TTM



Telomir Pharmaceuticals Inc

1.160

-0.100-7.94%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Telomir Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-98.30%-1.20M

7.49%-927.26K

54.27%-696.45K

55.50%-863.13K

44.28%-605.81K

49.96%-1.00M

---1.52M

---1.94M

-325.04%-1.09M

-2331.29%-2.00M

---255.79K

---82.39K

Net income from continuing operations

28.88%-2.06M

81.41%-1.10M

-249.89%-5.07M

65.15%-2.18M

68.93%-2.90M

-246.56%-5.93M

---1.45M

---6.25M

-1814.86%-9.33M

-632.91%-1.71M

---487.10K

---233.50K

Other non-cash items

-100.00%0.00

--840.00K

---1.00

----

-98.42%130.00K

-100.00%0.00

--0.00

--4.34M

--8.23M

--743.75K

----

Change in working capital

763.23%867.79K

-37.56%76.89K

-294.10%-291.00K

-152.62%-58.99K

337.08%100.53K

111.74%123.13K

---73.84K

---23.35K

-90.06%23.00K

-794.31%-1.05M

--231.31K

--151.10K

-Change in prepaid expenses

-6.91%18.13K

-76.42%2.47K

17.34%12.90K

69.10%-30.32K

7689.60%19.47K

1186.81%10.47K

--10.99K

---98.09K

--250.00

---963.00

----

-Change in payables and accrued expense

155.87%207.39K

-33.95%74.42K

-258.23%-303.90K

-138.36%-28.68K

256.29%81.06K

110.75%112.67K

---84.83K

--74.74K

-90.16%22.75K

-793.67%-1.05M

--231.31K

--151.10K

-Change in other current liabilities

--224.80K

----

Cash from non-recurring investing activities

Cash from operating activities

-98.30%-1.20M

7.49%-927.26K

54.27%-696.45K

55.50%-863.13K

44.28%-605.81K

49.96%-1.00M

---1.52M

---1.94M

-325.04%-1.09M

-2331.29%-2.00M

---255.79K

---82.39K

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

11.71%1.16M

16093.18%7.50M

691.14%1.05M

----

-4.48%1.04M

-102.36%-46.91K

--132.44K

--5.21M

332.87%1.09M

2388.86%1.99M

--250.88K

--80.00K

Net cash flow from debt Issuance/repayment

--0.00

2365.21%3.00M

----

-115.58%-132.44K

--132.44K

----

--1.83M

--850.00K

----

Net cash flow from common stock issuance/repurchase

0.32%1.00M

--4.50M

--1.05M

----

1011.11%1.00M

--0.00

--5.83M

--90.00K

--0.00

----

Proceeds from issuance of warrants

----

--37.30K

----

Net cash flow from other financing activities

15551700.00%155.52K

3407.58%3.00M

----

100.00%1.00

-92.50%85.53K

--0.00

---620.48K

-433.26%-836.08K

1326.36%1.14M

--250.88K

--80.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

11.71%1.16M

16093.18%7.50M

691.14%1.05M

----

-4.48%1.04M

-102.36%-46.91K

--132.44K

--5.21M

332.87%1.09M

2388.86%1.99M

--250.88K

--80.00K

Net cash flow

Beginning cash balance

778.14%7.33M

-59.96%754.32K

-87.69%403.00K

102753.86%1.27M

33939.07%834.64K

12777.91%1.88M

--3.27M

--1.23K

-61.26%2.45K

--14.63K

--6.33K

--0.00

Current period cash flow changes

-109.88%-42.63K

726.62%6.57M

125.27%351.32K

-126.37%-863.13K

35439.31%431.49K

-8516.83%-1.05M

---1.39M

--3.27M

75.14%-1.22K

-408.43%-12.18K

---4.91K

---2.40K

Ending cash balance

475.51%7.29M

778.14%7.33M

-59.96%754.32K

-87.69%403.00K

102753.86%1.27M

33939.07%834.64K

--1.88M

--3.27M

-13.25%1.23K

202.38%2.45K

--1.42K

---2.40K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

